Ostara Biomedical Limited in Liverpool, L3 5TF

Description

Data updated on: 01-11-2023

Ostara Biomedical Limited may be contacted at Liverpool Science Park Innovation Centre, 131 Mount Pleasant in Liverpool. The firm area code is L3 5TF. Ostara Biomedical has been on the British market since the firm was registered in 2012. The firm reg. no. is 08322823. The company's classified under the NACE and SIC code 74909 - Other professional, scientific and technical activities not elsewhere classified. The latest filed accounts documents cover the period up to 2022-01-31 and the most recent confirmation statement was filed on 2022-12-07.

The trademark of Ostara Biomedical is "PROGENYSYS". It was submitted for registration in September, 2015 and its registration was completed by trademark office in October, 2016. The company can use the trademark untill September, 2025.

The following company owes its well established position on the market and unending growth to a team of three directors, specifically Naseeb S., Paul H. and Nadia O., who have been running it since January 2020.

Trade marks

Trademark UK00003171332

Trademark UK00003171332

Trademark image:	-
Trademark name:	PROGENYSYS
Status:	Registered
Filing date:	2015-09-04
Date of entry in register:	2016-10-14
Renewal date:	2025-09-04
Owner name:	Ostara Biomedical Limited
Owner address:	Liverpool Science Park Innovation Centre, 131 Mount Pleasant, Liverpool, United Kingdom, L3 5TF

Financial data based on annual reports

Profit & Loss
Date of Accounts	2014-03-31	2015-03-31	2016-03-31
Currency
Net Worth	208 504	267 919	734 493

Balance Sheet
Cash Bank In Hand	106 026	237 908	681 447
Current Assets	150 278	267 468	750 390
Debtors	44 252	29 560	68 943
Intangible Fixed Assets	63 550	2	2
Net Assets Liabilities Including Pension Asset Liability	208 504	267 919	734 493
Tangible Fixed Assets	665	1 766	2 123

Capital & Reserves
Called Up Share Capital	163	223	363
Profit Loss Account Reserve	-106 596	-169 341	-823 158
Shareholder Funds	208 504	267 919	734 493

Other Financial Data
Director Remuneration Benefits Excluding Payments To Third Parties		96 000	119 147
Accruals Deferred Income Within One Year			5 755
Administrative Expenses		289 186	625 024
Corporation Tax Recoverable Current Asset Due Within One Year		24 000
Creditors Due Within One Year	5 989	1 317	18 022
Depreciation Other Amounts Written Off Tangible Intangible Fixed Assets			408
Fixed Assets	64 215
Increase Decrease In U K Corporation Tax Arising From Adjustment For Prior Periods		8 432	11 786
Intangible Fixed Assets Cost Or Valuation		2	2
Net Current Assets Liabilities	144 289	266 151	732 368
Nominal Value Shares Issued			0
Number Shares Allotted	16 300		3 500
Number Shares Issued			13 571
Other Creditors Due Within One Year		1 300	904
Other Operating Income		120 581	160 833
Par Value Share	0
Premium On Share Issues Share Premium Account- Gross			-979 860
Prepayments Accrued Income Current Asset Due Within One Year			45 666
Profit Loss For Period		-177 037	-475 977
Profit Loss On Ordinary Activities Before Tax		-168 605	-464 191
Research Development Costs		128 838	359 031
Share Capital Allotted Called Up Paid		35	35
Share Issues Expenses Share Premium Account			37 449
Share Premium Account	314 937	614 877	1 557 288
Tangible Fixed Assets Additions			765
Tangible Fixed Assets Cost Or Valuation		1 766	-2 531
Tangible Fixed Assets Depreciation			408
Tangible Fixed Assets Depreciation Charged In Period			408
Taxation Social Security Due Within One Year			5 393
Tax On Profit Or Loss On Ordinary Activities		8 432	11 786
Total Assets Less Current Liabilities		267 919	734 493
Total Recognised Gain Loss For Period		-177 037	-475 977
Trade Creditors Within One Year		17	5 970
U K Current Corporation Tax		8 432	11 786
Value Shares Allotted	163		0
V A T Due Within One Year		-5 560	-23 277